Memphasys

Follow
Get notifications in MyBN when activity occurs.
Subscribe to BN Log In

Memphasys Ltd (ASX: MEM) is an Australian public-listed bio-separations company developing and commercialising innovative separation techniques based on the company's proprietary membrane technology.

Contact Details

30 Richmond Road , HOMEBUSH WEST NSW 2140
02 8415 7300
www.memphasys.com

Lists and Charts

Share price

Memphasys
Closing price for the last 90 trading days
View ASX Chart
Powered by Morningstar ®

Company Share Transactions

30/12/22
$31 Bought
Memphasys
30/12/22
$5.39k Bought
Memphasys
30/12/22
$5.42k Bought
Memphasys
Total value as at the date of the transaction
Powered by Morningstar ®

Company Activity

 NEW ROLE: David Ali, Acting CEO, Executive Director 01 Aug 2024
NEW ROLE: Robert Cooke, Non-Executive Chairman, Non-Executive Director 01 Aug 2024
Michael Atkins
NEW ROLE: Michael Atkins, Non-Executive Director 01 Aug 2024
NEW ROLE: David Ali, 30 Oct 2023
NEW ROLE: Hassan Bakos, 30 Oct 2023
NEWS: Tagged in Memphasys to reinvest tax refund in the next generation 25 Oct 2023
NEWS: Tagged in Memphasys brings Indian baby dreams alive with Felix 15 Sep 2023
NEWS: Tagged in Memphasys franks Japan deal with first Felix order 14 Aug 2023
NEWS: Tagged in Memphasys inks deal with global IVF provider Vitrolife 07 Aug 2023
NEWS: Tagged in Memphasys locks in new patents for flagship IVF treatment 13 Jul 2023

News Articles

Related Information

X